Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research-Reference-Cited by-同舟云学术

Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research

Published:2017-06-08 Issue:4 Volume:10 Page:527-530
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Mühlbacher Axel C.,Johnson F. Reed

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1007/s40271-017-0249-5/fulltext.html

Reference15 articles.

1. Craig BM, Mühlbacher A, Lancsar E, Brown DS, Ostermann J. Health preference research: an overview. The Patient. 2017. doi: 10.1007/s40271-017-0253-9 .

2. Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29–40.

3. European Medicines Agency. Benefit-risk methodology project. Work package 2 report: applicability of current tools and processes for regulatory benefit-risk assessment. Revision 1. London: European Medicines Agency; 2010.

4. European Medicines Agency. Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting: meeting minutes. London: European Medicines Agency; 2013.

5. Mühlbacher A, Johnson FR. Choice experiments to quantify preferences for health and healthcare: state of the practice. Appl Health Econ Health Policy. 2016;14(3):253–66.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action;Frontiers in Pharmacology;2023-08-16

2. Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods;PharmacoEconomics - Open;2022-11-01

3. Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review;Expert Review of Pharmacoeconomics & Outcomes Research;2021-02-02

4. How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations;International Journal of Technology Assessment in Health Care;2021

5. Reporting Quality of Marginal Rates of Substitution in Discrete Choice Experiments That Elicit Patient Preferences;Value in Health;2020-08